Liudmyla Iashyna

Statistics

Publications

Citations

388

H-Index

Active since

2017

Affiliations

GlaxoSmithKline (India)(Current)

Semey Medical University

Liudmyla Iashyna is an author at GlaxoSmithKline (India) specializing in health sciences, chronic obstructive pulmonary disease epidemiology, and chronic obstructive pulmonary disease.

Publications per year

2017–2018

Publications

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study

Damilya Nugmanova, Y. I. Feshchenko, Liudmyla Iashyna et al. · BMC Pulmonary Medicine · 2018 · 57 citations · Full text

Public Health, Health Sciences, Epidemiology +15

Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the Commonwealth of Independent States: rationale and design of the CORE study

Y. I. Feshchenko, Liudmyla Iashyna, Damilya Nugmanova et al. · BMC Pulmonary Medicine · 2017 · 20 citations · Full text

Medicine, Health Sciences, Internal Medicine +16

1–3 of 3